$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
尼达尼布(Nintedanib)的用法用量:用药指南,剂量调整,特殊人群用药,用药注意事项
2025-10-19 11:44:20
Check Details
尼达尼布(Nintedanib)详细说明书:适应症、用法用量、副作用、注意事项
2025-10-19 11:44:20
Check Details
尼达尼布(Nintedanib)中文说明书
2025-10-19 11:44:20
Check Details
FDA批准尼达尼布(Nintedanib)用于治疗进展型慢性纤维化间质性肺疾病(ILD)
2025-10-19 11:44:20
Check Details
FDA批准尼达尼布(Nintedanib)用于治疗系统性硬化症或硬皮病相关间质性肺病(SSc-ILD)
2025-10-19 11:44:20
Check Details
吡非尼酮(Pirfenidone)中文说明书
2025-10-19 11:44:20
Check Details
吡非尼酮(Pirfenidone)的副作用和不良反应
2025-10-19 11:44:20
Check Details
吡非尼酮(Pirfenidone)纳入医保了吗?
2025-10-19 11:44:20
Check Details
吡非尼酮(Pirfenidone)在国内上市了吗?
2025-10-19 11:44:20
Check Details
尼达尼布(Nintedanib)纳入医保了吗?
2025-10-19 11:44:20
Check Details
注射用喷他脒多少钱一盒?在哪里购买?
2025-10-19 11:44:20
Check Details
注射用喷他脒有几种规格?
2025-10-19 11:44:20
Check Details
1
2
...
3846
3847
3848
3849
3850
3851
3852
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Daraxonrasib Pregnancy, Lactation and Contraception Safety
2
Afatinib Side Effects and Safety Management
3
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
4
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis
5
Key points for drug monitoring of Molotinib in bone marrow fibrosis
6
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
7
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
8
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data
9
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
10
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
11
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
12
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring